 |
DISEASE TOPICS:
Chronic
Kidney Failure
Hereditary
and Congenital Diseases in Purebred Dogs
Narcolepsy
Understanding Lab Tests
Diabetes
Colorado State University Small Animal
Vaccination Protocol
OUTSIDE LINKS:
optigen.com
Testing for Genetic Diseases, especially Progressive
Retinal Atrophy
petdiabetes.org
The Pet Diabetes Page
best.com/~lynxpt
The Feline Chronic Renal Failure Page
marvistavet.com
The
Canine Chronic Renal Failure Page
petloss.com
Special
Needs Links -- access to information on a variety of chronic diseases
GDC
Registries
GDC
maintains genetic disease registries for purebred dogs in the US and worldwide.
|
 |
 |
 |
COLORADO STATE UNIVERSITY SMALL
ANIMAL VACCINATION PROTOCOL
Background
In the past there have been many different vaccination recommendations
for dogs and cats from veterinarians across the United States based on
the best available information. In light of new information, the Colorado
State University Veterinary Teaching Hospital is offering its clients
the following vaccination program. This program is designed as the routine
immunization program for Colorado State University's clients' dogs and
cats living in Larimer County, Colorado, USA in conjunction with a complete
physical examination and health evaluation. This program is modified for
any patient with specific risk factors.
Not all available
small animal vaccines may be suitable for our program. Infectious disease
risk may vary and our routine vaccination program may not be suitable
for all localities. Anyone using our routine vaccination program is encouraged
to follow the guidelines that are its basis and use the program at their
own risk.
For pet owners,
your local veterinarian is your best resource to develop a vaccination
program tailored for your pet. The health status and infectious disease
risks of your pet should be considered in the selection of a vaccination
program.
Our adoption
of this routine vaccination program is based on the lack of scientific
evidence to support the current practice of annual vaccination and increasing
documentation showing that overvaccinating has been associated with harmful
side effects. Of particular note in this regard has been the association
of autoimmune hemolytic anemia with vaccination in dogs and vaccine-associated
sarcomas in cats -- both of which are often fatal. With boosters (except
for rabies vaccine), the annual revaccination recommendation on the vaccine
label is just that -- a recommendation without the backing of long term
duration of immunity studies, and is not a legal requirement. Rabies vaccine
is the only commonly used vaccine that requires that duration of immunity
studies be carried out before licensure in the United States. Even with
rabies vaccines, the label may be misleading in that a three year duration
of immunity product may also be labeled and sold as a one year duration
of immunity product.
Based on
the concern that annual vaccination of small animals for many, but not
all, infectious agents is probably no longer scientifcally justified,
and our desire to avoid vaccine-associated adverse events, we are recommending
the described routine immunization program to our small animal clients.
^BACK TO TOP
Vaccine
Schedule
This Program recommends the standard three shot series for puppies (parvovirus,
adenovirus 2, parainfluenza, distemper) and kittens (panleukopenia, rhinotracheitis,
calicivirus) to include rabies after 8 weeks of age for cats and 16 weeks
of age for dogs. Following the initial puppy and kitten immunization series,
cats and dogs will be boostered one year later and then every threeyears
thereafter for all the above diseases except for rabies in cats which
receive the new sater canary pox rabies vaccine that requires annual boosters.
Similar small animal vaccination programs have been recently adopted by
other university teaching hospitals and the American Association of Feline
Practitioners.
Other available
small animal vaccines, which may need more frequent administration, i.e.,
intranasal parainfluenza, Bordetella, feline leukemia, Lyme, etc., may
be recommended for CSU client animals on an "at risk" basis
but are not a part of the routine Colorado State University protocol for
small animals. Recent studies clearly indicate that not all vaccines perform
equally and some vaccine products may not be suitable for such a program.
NONROUTINE
VACCINE RECOMMENDATIONS
Intranasal
Bordetella/Parainfluenza
To be used just prior to possible exposure to kennel cough carriers, i.e.,
shows, field trials, etc. May be repeated up to six times per year.
Feline Leukemia
Vaccine
To be used ONLY IN HIGH RISK cats. Two vaccines prior to 12 weeks of age.
One booster at one year of age.
For those
interested in reading more about small animal immunization issues, the
following is a suggested reading list.
^BACK TO TOP
SMALL
ANIMAL VACCINES SELECTED FOR THE PROGRAM AT THE
COLORADO STATE UNIVERSITY VETERINARY TEACHING HOSPITAL
CANINE
| Brand
Name: |
Vaccine
Type: |
| Progard
®-5 |
Modified
live canine distemper, adenovirus type 2, parainfluenza, parvovirus
vaccine |
| Progard
® KC |
Canine
parainfluenza, Bordetella bronchiseptica (intranasal) |
| Imrab®
3 |
Killed
rabies vaccine - three year duration of immunity |
FELINE
| Brand
Name: |
Vaccine
Type: |
| Imrab®
3 |
Killed
rabies vaccine - three year duration of immunity |
| Protex
® -3 |
Feline
rhinotracheitis, calici, panleukopenia modified live virus |
| Trivalent |
Modified
live rhinotracheitis, calici, panleukopenia (intranasal) |
| Fel-O-Vax
Lv-K ® |
Killed
FeLV vaccine |
| Purvax |
A
new canarypox vector rabies vaccine from Merial with a one year duration
of immunity replaces Imrab®3 in cats. |
^BACK TO TOP
SUGGESTED
READING LIST
Dubielzig
RR, Everitt J, Shadduck JA, et al: Clinical and morphologic features of
posttraumatic ocular sarcomas in cats. Vet Pathol 27:62-65, 1990.
Dubielzig RR, Hawkins KL, Miller PE: Myofibroblastic sarcoma originating
at the site of rabies vaccination in a cat. J Vet Diagn Invest 5:637-638,
1993.
Duval D, Giger URS: Vaccine associated immune-mediated hemolytic anemia
in the dog. J Vet Int Med 10:290-295, 1996.
Esplin DG, McGill L, Meininger A, et al: Postvaccination sarcomas in cats.
J Am Vet Med Assoc 202:1245-1247, 1993.
Fawcett HA, Smith HP: Injection-site granuloma due to aluminum. Arch Dermatol
120:1318-1322, 1984.
Greene CE: Vaccine induced complications verses overvaccination. Proceedings
of the 65th annual AAHA meeting, Chicago, 1998, pp 368-369.
Hendrick MJ, Brooks JJ: Postvaccinal sarcomas in the cat: Histology and
immunohistochemistry. Vet Pathol 31:126-129, 1994.
Hendrick MJ, Dunagan C: Focal necrotizing granulomatous panniculitis associated
with subcutaneous injection of rabies vaccine in cats and dogs: 10 cases
(1988-1989) J Am Vet Med Assoc 198:304-305, 1991.
Hendrick MJ, Goldschmidt MH: Do injection site reactions induce fibrosarcomas
in cats? J Am Vet Med Assoc 199:968, 1991.
Hendrick MJ, Goldschmidt MH, Shofer F, et al: Postvaccinal sarcomas in
the cat: Epidemiology and electron probe microanalytical identification
of aluminum. Cancer Res 52:5391-5394, 1992.
Hendrick MJ, Kass PH, McGill LD, et al: Commentary: Postvaccinal sarcomas
in cats. J Natl Cancer Inst 96:5, 1994.
Hendrick MJ, Shofer FS, Goldschmidt MH, et al: Comparison of fibrosarcomas
that developed at vaccination sites and at nonvaccination sites in cats:
239 cases (1991-1992). J Am Vet Med Assoc 205:1425-1429, 1994.
Kass PH, Barnes WG, Spangler WL, et al: Epidemiologic evidence for a causal
relation between vaccination and fibrosarcoma tumorigenesis in cats. J
Am Vet Med Assoc 203:396-405, 1993.
Larson LV, Schultz RD: Comparison of selected canine vaccines for the
inability to induce protective immunity against canine parvovirus infections.
AJVR 1997 58:4, 360-363, 1997.
Larson RL, Bradley JS: Immunologic principles and immunization strategy.
Comp Cont Ed Pract Vet 1996;18:963-970.
Macy DW. The potential role and mechanisms of FeLV vaccine-induced neoplasms.
Sem Vet Med Surg 1995;10:234-238.
Macy DW, et al. Vaccine associated sarcomas in cats. Fel Pract 1995;23:24-27.
Macy DW, et al. Postvaccinal reactions associated with three rabies and
three leukemia virus vaccines in cats. Proc. 14th Annual Vet Cancer Soc
Cof., Veterinary Cancer Society, Townsend, Tenn., 1994:90-91.
Macy DW, Hendrick MJ: The potential role of inflammation in the development
of postvaccinal sarcomas in cats. Seminars in Vet Med and Surg 26:103-109,
1996.
Olson P, et al. Duration of immunity eliceited by canine distemper virus
vaccinatons in dogs. Vet Rec 1997;141:654-655.
Pedersen NC: Perspectives on small animal vaccination: A critical look
at current vaccines and vaccine strategies in the United States. Proceedings
AAHA 145-156, 1997.
Phillips TR, Schultz RD: Canine and feline vaccines. Kirk R and Bonagura
JD (eds). Current Veterinary Therapy XI, WB Saunders Co., Philadelphia,
1992, pp 202-206.
Schultz RD: Current and future canine and feline vaccination programs.
Veterinary Medicine 233-254, March 1998.
Schultz RD: Veterinary Vaccines and Diagnostics in Advances in Veterinary
Medicine, 41, 1999 pp. 1-853.
Scott FW: Duration of immunity in cats vaccinated with an inactivated
feline panleukopenia, herpesvirus, and calicivirus vaccine. Fel Pract
1997;25:12-22.
Smith CA: Current concepts: Are we vaccinating too much? J Am Vet Med
Assoc 207:421-425,1995.
Tizard I: Risks associated with the use of live vaccines. J Am Vet Med
Assoc 1990;196:1851-1858.
^BACK TO TOP |